Erik Davis says: I recently published my first column for Aeon Magazine's online site, a "post-secular" take on the current wave of psychedelic research. Without plunging into woo, the article attempts to chart the liminal zones that lie beyond brain-based reductionism. It seemed a good piece for Aeon, a new British outfit that is charting a very interesting zone between science, religion, culture, and good writing.
Studies recently carried out at Yale, and published last month in the journal Science, have confirmed earlier reports that ketamine offers remarkable, nearly instantaneous relief for people who suffer from forms of major depression impervious to other treatment methods. Interpreting depression as a hardware problem largely caused by the loss of synaptic connections, the researchers argue that ketamine works by encouraging sprightly neural growth in brain regions correlated with memory and mood. Journalistic reports also linked this research with the development of a new vein of antidepressants, including Naurex’s GLYX-13, that have the neurone-fertilising power of ketamine without, as one report describes them, the ‘schizophrenia-like effects’.
Rarely has the new neuro-reductionism been so naked in its repackaging of human experience. Nowhere in the research or the journalism does anyone suggest that heavily depressed people feel better because ketamine sends them on a first-person voyage through profound, sometimes ecstatic, and certainly mind-bending modes of transpersonal consciousness whose subjective power might itself boot the mind out of its most mirthless ruts.
Return trip: A new generation of researchers is heading into the weird world of psychedelic drugs. It could change their minds
Jan Hoffman writes about recent research into the effects on psychedelics such as psilocybin on anxiety and depression: “About 80 percent of cancer patients showed clinically significant reductions in both psychological disorders, a response sustained some seven months after the single dose.” Dr. Jeffrey Lieberman, a past president of the American Psychiatric Association, and Dr. […]
Johns Hopkins is among several institutions challenging a key tenet of outlawing psychedelics: that they have “no medicinal use.” Baltimore Magazine examines the progress made by key researchers Roland Griffiths and Bill Richards.
Once the domain of countercultural psychonauts, LSD and mushrooms in one-tenth doses are becoming more popular among you professionals, especially in the tech industry.
Holiday shopping is in full swing, and the Striiv Touch is one of the best gift ideas I’ve landed on. Its simple design works for females and males, and its wide range of features makes it suitable for even the non-fitness enthusiasts in your life.Unlike traditional fitness trackers, the Striiv Touch also acts as a smartwatch. It […]
The Pocket Tripod PRO had massive Kickstarter success in 2013, raising almost $85,000 in a single month. But this isn’t just another case of pre-release product hype. This ingenious little device folds out from a credit-card-shaped plastic slab into a sturdy stand with a surprisingly wide range of motion. In portrait orientation, your phone slides […]
Loot Crate is a totally different kind of subscription service that mails subscribers monthly boxes filled with curated geek, pop culture, and gamer paraphernalia. Its cult following awaits a box every month filled with everything from bobble heads to T-shirts to special edition collectibles. But nothing gets Loot Crate fans as excited as the limited […]